Description: Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.
Home Page: www.hutch-med.com
HCM Technical Analysis
Cheung Kong Center
Central,
Hong Kong
Phone:
852 2128 1188
Officers
| Name | Title |
|---|---|
| Mr. Chi Keung To ACGI, B.Sc., BSc, M.B.A., MBA | Exec. Chairman |
| Dr. Weiguo Su B.Sc., Ph.D. | CEO, Chief Scientific Officer & Exec. Director |
| Mr. Chig Fung Cheng BEc, CA | CFO & Exec. Director |
| Ms. Edith Shih C.S., CGP, FCS, M.A., P.E., BSE, EdM, Solicito | Company Sec. & Non-Exec. Director |
| Dr. Karen Jane Atkin | Exec. VP & COO |
| Mr. Kin Hung Lee M.B.A. | Sr. VP of Corp. Fin. & Devel. |
| Mr. Charles George Rupert Nixon | Group Gen. Counsel |
| Ms. Selina Zhang | Sr. VP of Global HR |
| Dr. Qingmei Wang Ph.D. | Sr. VP of Bus. Devel. & Strategic Alliances |
| Mr. Hong Chen | Sr. VP & Chief Commercial Officer- China |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.1092 |
| Price-to-Sales TTM: | 4.93 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2110 |